DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
2. 筋萎縮性側索硬化症
Amyotrophic lateral sclerosis
Clinical trials
/
Disease details
臨床試験数
:
624
/
薬物数
:
611
- (
DrugBank
:
160
) /
標的遺伝子数
:
172
-
標的パスウェイ数
:
225
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2020-005069-15-NL
(
EUCTR
)
23/06/2021
14/04/2021
LIGHTHOUSE 2
RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 TRIAL OF TRIUMEQ IN AMYOTROPHIC LATERAL SCLEROSIS - Lighthouse 2
RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 TRIAL OF TRIUMEQ IN AMYOTROPHIC LATERAL SCLEROSIS ...
Amyotrophic Lateral Sclerosis (ALS)
MedDRA version: 21.1;Level: PT;Classification code 10002026;Term: Amyotrophic lateral sclerosis;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
Amyotrophic Lateral Sclerosis (ALS)
MedDRA version: 21.1;Level: PT;Classification code 10002026;Term ...
Trade Name:
Triumeq
Product Name:
Triumeq
INN or Proposed INN:
Dolutegravir
INN or Proposed INN:
Abacavir
INN or Proposed INN:
Lamivudine
Trade Name:
Triumeq
Product Name:
Triumeq
INN or Proposed INN:
Dolutegravir
INN or Proposed INN:
Abacav
...
Stichting TRICALS Foundation
NULL
Authorised-recruitment may be ongoing or finished
Female: yes
Male: yes
390
Phase 3
Australia;Netherlands;United Kingdom